LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy

Yükleniyor...
Küçük Resim

Tarih

2018-09-06

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

NATURE PUBLISHING GROUP

Erişim Hakkı

info:eu-repo/semantics/openAccess

Özet

The potential of altering the tumor ECM to improve drug response remains fairly unexplored. To identify targets for modification of the ECM aiming to improve drug response and overcome resistance, we analyzed expression data sets from pre-treatment patient cohorts. Cross-evaluation identified a subset of chemoresistant tumors characterized by increased expression of collagens and collagen-stabilizing enzymes. We demonstrate that strong collagen expression and stabilization sets off a vicious circle of self-propagating hypoxia, malignant signaling, and aberrant angiogenesis that can be broken by an appropriate auxiliary intervention: Interfering with collagen stabilization by inhibition of lysyl oxidases significantly enhanced response to chemotherapy in various tumor models, even in metastatic disease. Inhibition of collagen stabilization by itself can reduce or enhance tumor growth depending on the tumor type. The mechanistical basis for this behavior is the dependence of the individual tumor on nutritional supply on one hand and on high tissue stiffness for FAK signaling on the other.

Açıklama

Anahtar Kelimeler

LYSYL OXIDASE, TUMOR ANGIOGENESIS, DRUG-DELIVERY, DOUBLE-BLIND, PHASE-II, DOXORUBICIN, IMPROVES, COMBINATION, SIMTUZUMAB, INHIBITION

Kaynak

ONCOGENE

WoS Q Değeri

Q1

Scopus Q Değeri

Cilt

Sayı

Künye